The value of inflammatory indexes in colorectal cancers

tarım, ismail alper; derebey, murat; Karabacak, Ufuk

doi:10.5455/medscience.2023.03.043

The value of inflammatory indexes in colorectal cancers

Ufuk KARABACAK, (Sivas Numune Hastanesi, Cerrahi Onkoloji Anabilim Dalı, Sivas, Türkiye)

Murat DEREBEY, (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Genel Cerrahi Anabilim Dalı, Samsun, Türkiye)

İSMAİL ALPER TARIM (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Genel Cerrahi Anabilim Dalı, Samsun, Türkiye)

Medicine Science

0 0

Yıl: 2023 Cilt: 12 Sayı: 2 Sayfa Aralığı: 453 - 457 Metin Dili: İngilizce DOI: 10.5455/medscience.2023.03.043 İndeks Tarihi: 12-07-2023

The value of inflammatory indexes in colorectal cancers

Öz:

In recent years, a relationship has been established between inflammatory indexes and the prognosis of many cancers. Although there are many studies investigating their relationship with colorectal cancers (CRC), there is a serious difference between the results in the related literature. The present study aimed to share our own experience with inflammatory indexes in CRC patients. Patients with a diagnosis of CRC who underwent surgery between January 2019 and June 2022 were retrospectively scanned. Exclusion criteria were as follows; being in a septic state before surgery, accompanying hematological disease, receiving neoadjuvant chemotherapy/radiotherapy, being diagnosed with recurrent CRC, undergoing emergency surgery, receiving immunosuppressive or anti-inflammatory treatment. Therefore, the study was conducted with 52 patients. Demographic information, tumor localization, stages and pathology data of the patients were examined. The relationship between these variables and the systemic immune-inflammation index (SII), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) was investigated. A significant correlation was found between pathological T stages and SII (p=0.008), NLR (p<0.001) and PLR (p=0.035). No correlation was found between inflammatory indexes and Age, Tumor Diameter, N Stage, Total Lymph Node Count, Metastatic Lymph Node Count. In our study, inflammatory indexes were found to be associated only with the T stage. Considering our results together with the variable results in the literature, more evidence is needed for the safe and active use of SII, NLR and PLR as markers of colorectal cancers.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.
2. Mattiuzzi C, Sanchis-Gomar F, Lippi G. Concise update on colorectal cancer epidemiology. Ann Transl Med. 2019;7:609.
3. Dong M, Shi Y, Yang J, et al. Prognostic and clinicopathological significance of systemic immune-inflammation index in colorectal cancer: a meta-analysis. Ther Adv Med Oncol. 2020;12:1758835920937425.
4. Ostan R, Lanzarini C, Pini E, et al. Inflammaging and cancer: a challenge for the mediterranean diet. Nutrients. 2015;7:2589-621.
5. Valdés-Rives SA, González-Arenas A. Autotaxin-lysophosphatidic acid: from inflammation to cancer development. Mediators Inflamm. 2017;2017:9173090.
6. Hosseini F, Mahdian-Shakib A, Jadidi-Niaragh F, et al. Anti-inflammatory and anti-tumor effects of α-l-guluronic acid (g2013) on cancer-related inflammation in a murine breast cancer model. Biomed Pharmacother. 2018;98:793-800.
7. Moses K, Brandau S. Human neutrophils: their role in cancer and relation to myeloid-derived suppressor cells. Semin Immunol. 2016;28:187-96.
8. Zhang X, Zhang W, Yuan X, et al. Neutrophils in cancer development and progression: roles, mechanisms, and implications. Int J Oncol. 2016;49:857-67.
9. Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood. 2015;126:582-8.
10. Li N. Platelets in cancer metastasis: to help the "villain" to do evil. Int J Cancer. 2016;138:2078-87.
11. Shibutani M, Maeda K, Nagahara H, et al. The peripheral monocyte count is associated with the density of tumor-associated macrophages in the tumor microenvironment of colorectal cancer: a retrospective study. BMC cancer. 2017;17:404.
12. Mohammed ZM, Going JJ, Edwards J, McMillan DC. The role of the tumour inflammatory cell infiltrate in predicting recurrence and survival in patients with primary operable breast cancer. Cancer Treat Rev. 2012;38:943-55.
13. Ferrone C, Dranoff G. Dual roles for immunity in gastrointestinal cancers. J Clin Oncol. 2010;28:4045-51.
14. Huang QT, Zhou L, Zeng WJ, et al. Prognostic significance of neutrophil- to-lymphocyte ratio in ovarian cancer: a systematic review and meta- analysis of observational studies. Cell Physiol Biochem. 2017;41:2411-8.
15. Cummings M, Merone L, Keeble C, et al. Preoperative neutrophil:lymphocyte and platelet: lymphocyte ratios predict endometrial cancer survival. Br J Cancer. 2015;113:311-20.
16. Zheng Z, Zhou L, Gao S, et al. Prognostic role of c-reactive protein in hepatocellular carcinoma: a systematic review and meta-analysis. Int J Med Sci. 2013;10:653-64.
17. Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23:6261-72.
18. Yang J, Xu H, Guo X, et al. Pretreatment inflammatory indexes as prognostic predictors for survival in colorectal cancer patients receiving neoadjuvant chemoradiotherapy. Sci Rep. 2018;8:3044.
19. Zhou ZQ, Pang S, Yu XC, et al. Predictive values of postoperative and dynamic changes of inflammation indexes in survival of patients with resected colorectal cancer. Curr Med Sci. 2018;38:798-808.
20. Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20:6212-22.
21. Yang R, Chang Q, Meng X, et al. Prognostic value of systemic immune- inflammation index in cancer: a meta-analysis. J Cancer. 2018;9:3295- 302.
22. Li Y, Jia H, Yu W, et al. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection. Int J Cancer. 2016;139:220-31.
23. Zou ZY, Liu HL, Ning N, et al. Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer. Oncol Lett. 2016;11:2241-48.
24. Passardi A, Scarpi E, Cavanna L, et al. Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer. Oncotarget. 2016;7:33210-9.
25. Xie QK, Chen P, Hu WM, et al. The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor. J Transl Med. 2018;16:273.
26. Tao MY, Wang ZH, Zhang MH, et al. Prognostic value of the systematic immune-inflammation index among patients with operable colon cancer: a retrospective study. Medicine (Baltimore). 2018;97:e13156.
27. Sato R, Oikawa M, Kakita T, et al. A decreased preoperative platelet- to-lymphocyte ratio, systemic immune-inflammation index, and pan- immune-inflammation value are associated with the poorer survival of patients with a stent inserted as a bridge to curative surgery for obstructive colorectal cancer. Surg Today. 2023;53:409-19.
28. Andersen CL, Tesfa D, Siersma VD, et al. Prevalence and clinical significance of neutropenia discovered in routine complete blood cell counts: a longitudinal study. J Intern Med. 2016;279:566-75.
29. George JN, Raskob GE, Shah SR, et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med. 1998;129:886-90.
30. Herishanu Y, Rogowski O, Polliack A, et al. Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur J Haematol. 2006;76:516-20.
31. Juneja S, Januszewicz E, Wolf M, Cooper I. Post-splenectomy lymphocytosis. Clin laborat haematol. 1995;17:335-7.
32. Lawrence YR, Raveh D, Rudensky B, Munter G. Extreme leukocytosis in the emergency department. QJM. 2007;100:217-23.
33. McBride JA, Dacie JV, Shapley R. The effect of splenectomy on the leucocyte count. Br J Haematol. 1968;14:225-31.
34. Milcic TL. The complete blood count. Neonatal Netw. 2010;29:109-15.
35. Pouchot J, Sampalis JS, Beaudet F, et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore). 1991;70:118-36.
36. Schafer AI. Thrombocytosis. N Engl J Med. 2004;350:1211-9.
37. Teggatz JR, Parkin J, Peterson L. Transient atypical lymphocytosis in patients with emergency medical conditions. Arch Pathol Lab Med. 1987;111:712-4.
38. Vetsika EK, Callan M. Infectious mononucleosis and epstein-barr virus. Expert Rev Mol Med. 2004;6:1-16.

APA	Karabacak U, derebey m, tarım i (2023). The value of inflammatory indexes in colorectal cancers. , 453 - 457. 10.5455/medscience.2023.03.043
Chicago	Karabacak Ufuk,derebey murat,tarım ismail alper The value of inflammatory indexes in colorectal cancers. (2023): 453 - 457. 10.5455/medscience.2023.03.043
MLA	Karabacak Ufuk,derebey murat,tarım ismail alper The value of inflammatory indexes in colorectal cancers. , 2023, ss.453 - 457. 10.5455/medscience.2023.03.043
AMA	Karabacak U,derebey m,tarım i The value of inflammatory indexes in colorectal cancers. . 2023; 453 - 457. 10.5455/medscience.2023.03.043
Vancouver	Karabacak U,derebey m,tarım i The value of inflammatory indexes in colorectal cancers. . 2023; 453 - 457. 10.5455/medscience.2023.03.043
IEEE	Karabacak U,derebey m,tarım i "The value of inflammatory indexes in colorectal cancers." , ss.453 - 457, 2023. 10.5455/medscience.2023.03.043
ISNAD	Karabacak, Ufuk vd. "The value of inflammatory indexes in colorectal cancers". (2023), 453-457. https://doi.org/10.5455/medscience.2023.03.043

APA	Karabacak U, derebey m, tarım i (2023). The value of inflammatory indexes in colorectal cancers. Medicine Science, 12(2), 453 - 457. 10.5455/medscience.2023.03.043
Chicago	Karabacak Ufuk,derebey murat,tarım ismail alper The value of inflammatory indexes in colorectal cancers. Medicine Science 12, no.2 (2023): 453 - 457. 10.5455/medscience.2023.03.043
MLA	Karabacak Ufuk,derebey murat,tarım ismail alper The value of inflammatory indexes in colorectal cancers. Medicine Science, vol.12, no.2, 2023, ss.453 - 457. 10.5455/medscience.2023.03.043
AMA	Karabacak U,derebey m,tarım i The value of inflammatory indexes in colorectal cancers. Medicine Science. 2023; 12(2): 453 - 457. 10.5455/medscience.2023.03.043
Vancouver	Karabacak U,derebey m,tarım i The value of inflammatory indexes in colorectal cancers. Medicine Science. 2023; 12(2): 453 - 457. 10.5455/medscience.2023.03.043
IEEE	Karabacak U,derebey m,tarım i "The value of inflammatory indexes in colorectal cancers." Medicine Science, 12, ss.453 - 457, 2023. 10.5455/medscience.2023.03.043
ISNAD	Karabacak, Ufuk vd. "The value of inflammatory indexes in colorectal cancers". Medicine Science 12/2 (2023), 453-457. https://doi.org/10.5455/medscience.2023.03.043